Keywords: Almirall, Kyorin Oharma, Aclidinium, COPD, Japan License

Almirall and Kyorin in 38 million-euro licensing deal for COPD drug in Japan

Article | 25 February 2011

Print This

Spain’s largest drugmaker Almirall (ALM.MC) has entered into an accord with Japan’s Kyorin Pharmaceutical (TSE; 4569) ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in